Fluent Financial, LLC Catalent, Inc. Transaction History

Fluent Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$41.39 - $81.0 $720,020 - $1.41 Million	-17,396 Reduced 70.25%	7,367 $331,000
Q3 2022 Oct 31, 2022	BUY	$72.36 - $113.1 $406,735 - $635,735	5,621 Added 29.36%	24,763 $1.79 Million
Q2 2022 Aug 04, 2022	SELL	$87.2 - $114.05 $252,880 - $330,745	-2,900 Reduced 13.16%	19,142 $2.05 Million
Q1 2022 May 10, 2022	BUY	$94.19 - $124.49 $2.08 Million - $2.74 Million	22,042 New	22,042 $2.45 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Fluent Financial, LLC with notifications on news.